510(k) · Cleared
ClearedDyeVert™ NG Contrast Reduction System, DyeVert™ PLUS EZ Contrast Reduction System, DyeTect™ Contrast Monitoring Disposable Kit, Smart Syringe, DyeVert™ PLUS EZ Contrast Reduction System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Osprey Medical, Inc. · DXT Injector And Syringe, Angiographic
Cleared on Dec 20, 2018 as substantially equivalent to K161505 (Osprey Medical, Inc., 2016) and 4 other predicates after a 27-day review. Its family tree reaches back 12 generations to 1982.
- Decided
- Dec 20, 2018
- Review
- 27 days
- Class
- Class II
- Product code
- DXT
- Recalls
- None
- Predicates
- 5
Its longest line of descent runs back 12 generations to K822536 (1982). 23 ancestors in all. No later device cites it as a predicate yet.
- Root · 12 generations backK822536 MARK VMedrad, Inc. · 1982
- 8 generations between
- 3 generations backK161505 DyeVert NG Contrast Modulation SystemOsprey Medical, Inc. · 2016
- 2 generations backK163054 DyeVert Plus Contrast Modulation/Monitoring System, Contrast…Osprey Medical, Inc. · 2017
- 1 generation backK171217 DyeVert Plus Contrast Reduction System, DyeVert NG Contrast…Osprey Medical, Inc. · 2017
- This deviceK183267 DyeVert™ NG Contrast Reduction System, DyeVert™ PLUS EZ Contrast…Osprey Medical, Inc. · 2018
Show all 12 generations
- Root · 12 generations backK822536 MARK VMedrad, Inc. · 1982
- 11 generations backK963982 Acist Angiographic InjectorInvasatec · 1997
- 10 generations backK984058 Acist Injector System, Model CL100 HAcist Medical Systems · 1999
- 9 generations backK991103 Modification to Acist CL 100HAcist Medical Systems · 2000 · Recalled
- 8 generations backK131478 Contrast Conservation SystemOsprey Medical, Inc. · 2013
- 7 generations backK140425 Contrast Modulation SystemOsprey Medical, Inc. · 2014
- 6 generations backK150485 AVERT Contrast Modulation SystemOsprey Medical, Inc. · 2015
- 5 generations backK151300 AVERT Contrast Modulation SystemOsprey Medical, Inc. · 2015
- 4 generations backK153141 DyeVert Contrast Modulation SystemOsprey Medical, Inc. · 2016
- 3 generations backK161505 DyeVert NG Contrast Modulation SystemOsprey Medical, Inc. · 2016
- 2 generations backK163054 DyeVert Plus Contrast Modulation/Monitoring System, Contrast…Osprey Medical, Inc. · 2017
- 1 generation backK171217 DyeVert Plus Contrast Reduction System, DyeVert NG Contrast…Osprey Medical, Inc. · 2017
- This deviceK183267 DyeVert™ NG Contrast Reduction System, DyeVert™ PLUS EZ Contrast…Osprey Medical, Inc. · 2018
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −12 | K822536 | MARK V | Medrad, Inc. | 1982 | — |
| −11 | K963982 | Acist Angiographic Injector | Invasatec | 1997 | — |
| −10 | K984058 | Acist Injector System, Model CL100 H | Acist Medical Systems | 1999 | — |
| −9 | K991103 | Modification to Acist CL 100H | Acist Medical Systems | 2000 | 3 |
| −8 | K131478 | Contrast Conservation System | Osprey Medical, Inc. | 2013 | — |
| −7 | K140425 | Contrast Modulation System | Osprey Medical, Inc. | 2014 | — |
| −6 | K150485 | AVERT Contrast Modulation System | Osprey Medical, Inc. | 2015 | — |
| −5 | K151300 | AVERT Contrast Modulation System | Osprey Medical, Inc. | 2015 | — |
| −4 | K153141 | DyeVert Contrast Modulation System | Osprey Medical, Inc. | 2016 | — |
| −3 | K161505 | DyeVert NG Contrast Modulation System | Osprey Medical, Inc. | 2016 | — |
| −2 | K163054 | DyeVert Plus Contrast Modulation/Monitoring System, Contrast Monitoring System | Osprey Medical, Inc. | 2017 | — |
| −1 | K171217 | DyeVert Plus Contrast Reduction System, DyeVert NG Contrast Reduction System | Osprey Medical, Inc. | 2017 | — |
| 0 (this device) | K183267 | DyeVert™ NG Contrast Reduction System, DyeVert™ PLUS EZ Contrast Reduction… | Osprey Medical, Inc. | 2018 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1991 | 1 | 0 |
| 1996 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2005 | 1 | 0 |
| 2011 | 1 | 0 |
| 2014 | 1 | 0 |
| 2015 | 1 | 0 |
| 2017 | 1 | 0 |
| 2018 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DXT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DXT device
- #1 K253048 High Pressure Syringe; Pressure Connecting…score 13.6 · 9 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (5)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K161505 | DyeVert NG Contrast Modulation SystemSummary page 5…CDRH/Interventional Cardiology Devices Branch (ICDB) Predicate Device Trade Name: DyeVert™ NG Contrast Reduction System Predicate Device 510(k) Number(s): K161505(initial), K171217 (subsequent design change from machined to injection-molded components)… | 2016 |
| * | K171217 | DyeVert Plus Contrast Reduction System, DyeVert NG Contrast Reduction SystemSummary page 5…al Cardiology Devices Branch (ICDB) Predicate Device Trade Name: DyeVert™ NG Contrast Reduction System Predicate Device 510(k) Number(s): K161505(initial), K171217 (subsequent design change from machined to injection-molded components) Trade Name/Propri… | 2017 |
| * | K163054 | DyeVert Plus Contrast Modulation/Monitoring System, Contrast Monitoring SystemSummary page 5…DRH/Interventional Cardiology Devices Branch (ICDB) Predicate Device Trade Name: DyeVert™ Plus Contrast Reduction System Predicate Device 510(k) Number(s): K163054 (initial), K171217 (subsequent design change from machined to injection-molded components)… | 2017 |
| * | K171698 | Smart SyringeSummary page 6…: CDRH/Interventional Cardiology Devices Branch (ICDB) Predicate Device Trade Name: Smart Syringe Predicate Device 510(k) Number(s): K171698 Trade Name/Proprietary Name: DyeVert™ Plus EZ Contrast Reduction System Common Name: Injec… | 2017 |
| * | K181936 | DyeVert PLUS EZ Contrast Reduction SystemSummary page 6…nterventional Cardiology Devices Branch (ICDB) Predicate Device Trade Name: DyeVert™ Plus EZ Contrast Reduction System Predicate Device 510(k) Number(s): K181936 Device Description: The DyeVert NG, DyeVert PLUS and DyeVert PLUS EZ Systems are compatible to manual contrast injections and pr… | 2018 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 36 years and passes through 4 companies; a new generation was cleared every 10 months on median.
- 3 of the 23 ancestors have a recall of any class.
- 2 other devices also cite its predicate K161505.
How does its category compare?
All DXT devicesDXT Injector And Syringe, Angiographic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.
FDA decisions per year · DXT
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · DXT
138in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · DXT
10in 2024
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · DXT
97in 2025
MAUDE reports naming product code DXT, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 3 | 182 | 4 | 107 |
| 2008 | 2 | — | 3 | 168 |
| 2009 | 6 | 137 | 7 | 188 |
| 2010 | 1 | — | 3 | 124 |
| 2011 | 4 | 69 | 3 | 133 |
| 2012 | 0 | — | 7 | 135 |
| 2013 | 2 | — | 0 | 141 |
| 2014 | 6 | 144 | 0 | 97 |
| 2015 | 7 | 153 | 1 | 135 |
| 2016 | 8 | 172 | 0 | 152 |
| 2017 | 7 | 183 | 0 | 128 |
| 2018 | 9 | 93 | 2 | 129 |
| 2019 | 4 | 96 | 0 | 121 |
| 2020 | 3 | 154 | 1 | 93 |
| 2021 | 1 | — | 1 | 132 |
| 2022 | 0 | — | 0 | 111 |
| 2023 | 1 | — | 2 | 117 |
| 2024 | 4 | 138 | 10 | 118 |
| 2025 | 1 | — | 0 | 97 |
| 2026 | 7 | 264 | 6 | — |
What is it indicated for?
The DyeVert™ NG Contrast Reduction System is to be used for the controlled infusion and contrast volume reduction of radiopaque contrast media for angiographic procedures with the following agents: Iodixanol 270 or 320 mgI/mL, Iohexol 300 or 350 mgI/mL and Iopamidol 370 mgI/mL. The DyeVert™ Plus Contrast Reduction System consists of a Display and DyeVert Plus Disposable Kit. The system is to be used for contrast volume reduction and for the monitoring of…
Read the full statement (275 words)
The DyeVert™ NG Contrast Reduction System is to be used for the controlled infusion and contrast volume reduction of radiopaque contrast media for angiographic procedures with the following agents: Iodixanol 270 or 320 mgI/mL, Iohexol 300 or 350 mgI/mL and Iopamidol 370 mgI/mL.
The DyeVert™ Plus Contrast Reduction System consists of a Display and DyeVert Plus Disposable Kit. The system is to be used for contrast volume reduction and for the monitoring of radiopaque contrast media during angiographic or CT procedures with the following agents: Iodixanol 270 or 320 mgI/mL, Iohexol 300 or 350 mgI/mL and Iopamidol 370 mgI/mL.
The DyeTect™ Contrast Monitoring Disposable Kit consists of a Smart Syringe and Pressure Module to be used with the Contrast Monitoring Display during angiographic or CT procedures requiring controlled infusion of radiopaque contrast media.
The Smart Syringe is to be used with the DyeVert™ Plus Contrast Reduction System or the Contrast Monitoring System. The DyeVert™ Plus Contrast Reduction System is to be used for contrast volume reduction and for the monitoring of radiopaque contrast media during angiographic or CT procedures with the following agents: Iodixanol 270 or 320 mgI/mL, Iohexol 300 or 350 mgI/mL and Iopamidol 370 mgI/mL. The Contrast Monitoring System is to be used during angiographic or CT procedures requiring controlled infusion of radiopaque contrast media.
The DyeVert™ Plus EZ Contrast Reduction System consists of a Display and DyeVert Plus EZ Disposable Kit. The system is to be used for contrast volume reduction and for the monitoring of radiopaque contrast media during angiographic or CT procedures with the following agents: Iodixanol 270 or 320 mgI/mL, Iohexol 300 or 350 mgI/mL and Iopamidol 370 mgI/mL.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K183267 · printed Nov 6, 2026
Cite this page
510(k) Report. “K183267: DyeVert™ NG Contrast Reduction System, DyeVert™ PLUS EZ Contrast Reduction System, DyeTect™ Contrast Monitoring Disposable Kit, Smart Syringe, DyeVert™ PLUS EZ Contrast Reduction System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K183267
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026